NanoViricides (NYSE-A:NNVC), a clinical-stage leader in broad-spectrum antiviral nanomedicine, will participate in the D. Boral Capital Inaugural Global Conference on May 14, 2025, at The Plaza Hotel, NYC.
President and Executive Chairman Anil Diwan will host one-on-one meetings from 9:00 A.M. to 3:00 P.M. ET.
To register, contact John Perez at jperez@dboralcapital.com.